Biodesix Inc. Company Profile
NASDAQ: BDSXHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Biodesix at a glance
Biodesix Inc. (NASDAQ: BDSX) is a Medical Specialities company in the Health Care sector headquartered in Louisville, CO. Biodesix is led by Mr. Scott Hutton and employs about 334 people. The company's shares have traded publicly since 2020.
At a market capitalization of $83.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001439725, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Biodesix do?
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Business description based on the company's public filings.
Company information
- Legal name
- Biodesix Inc.
- Ticker
- NASDAQ: BDSX
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Scott Hutton
- Employees
- 334
- Headquarters
- 919 West Dillon Road, Louisville, CO, United States
- Phone
- 303 417 0500
- Website
- biodesix.com
- IPO year
- 2020
- Market cap
- $83.83M
- SEC CIK
- 0001439725
- Latest annual report
- 10-K · Feb 26, 2026
Companies similar to Biodesix
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XGNExagen Inc. | 3.61 | -5.00% | $92.10M | vs BDSX |
| SERASera Prognostics Inc. Class A | 1.81 | -4.23% | $71.98M | vs BDSX |
| KEQUKewaunee Scientific Corporation | 33.55 | -2.75% | $97.14M | vs BDSX |
| BNRBurning Rock Biotech Limited ADR | 13.24 | -0.60% | $139.63M | vs BDSX |
| TLSITriSalus Life Sciences Inc. | 2.32 | +6.67% | $143.14M | vs BDSX |
| MDXHMDxHealth SA | 0.1074 | -8.52% | $10.25M | vs BDSX |
| AMSAmerican Shared Hospital Services | 1.00 | -4.76% | $6.67M | vs BDSX |
| ACONAclarion Inc. | 1.22 | -13.92% | $3.52M | vs BDSX |